Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Public ClinicalTrials.gov record NCT02953704. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Prospective, Longitudinal, Non-Interventional Study of Disease Burden and Treatment of Patients With Low-Risk Myelofibrosis (MF) or High-Risk Essential Thrombocythemia (ET) or ET Patients Receiving ET-Directed Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this prospective, longitudinal, noninterventional study is to describe clinical characteristics, evolution of disease burden, and treatment patterns in patients with select subcategories of essential thrombocythemia (ET) or myelofibrosis (MF).
Study identification
- NCT ID
- NCT02953704
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 1,469 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 30, 2016
- Primary completion
- Mar 28, 2022
- Completion
- Mar 28, 2022
- Last update posted
- May 12, 2022
2016 – 2022
United States locations
- U.S. sites
- 114
- U.S. states
- 40
- U.S. cities
- 114
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Huntsville | Alabama | — | — |
| Not listed | Tempe | Arizona | — | — |
| Not listed | Tucson | Arizona | — | — |
| Not listed | Little Rock | Arkansas | — | — |
| Not listed | Berkeley | California | — | — |
| Not listed | Highland | California | — | — |
| Not listed | Long Beach | California | — | — |
| Not listed | Oceanside | California | — | — |
| Not listed | Palo Alto | California | — | — |
| Not listed | Santa Rosa | California | — | — |
| Not listed | Aurora | Colorado | — | — |
| Not listed | Colorado Springs | Colorado | — | — |
| Not listed | Fort Collins | Colorado | — | — |
| Not listed | Middletown | Connecticut | — | — |
| Not listed | Washington D.C. | District of Columbia | — | — |
| Not listed | Aventura | Florida | — | — |
| Not listed | Boynton Beach | Florida | — | — |
| Not listed | Fort Lauderdale | Florida | — | — |
| Not listed | Jacksonville | Florida | — | — |
| Not listed | Pembroke Pines | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | Winter Haven | Florida | — | — |
| Not listed | Columbus | Georgia | — | — |
| Not listed | Marietta | Georgia | — | — |
| Not listed | Thomasville | Georgia | — | — |
| Not listed | Boise | Idaho | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Elk Grove Village | Illinois | — | — |
| Not listed | Harvey | Illinois | — | — |
| Not listed | Maywood | Illinois | — | — |
| Not listed | Normal | Illinois | — | — |
| Not listed | River Forest | Illinois | — | — |
| Not listed | Skokie | Illinois | — | — |
| Not listed | Anderson | Indiana | — | — |
| Not listed | Avon | Indiana | — | — |
| Not listed | Indianapolis | Indiana | — | — |
| Not listed | Terre Haute | Indiana | — | — |
| Not listed | Ames | Iowa | — | — |
| Not listed | Topeka | Kansas | — | — |
| Not listed | Westwood | Kansas | — | — |
| Not listed | Danville | Kentucky | — | — |
| Not listed | Mount Sterling | Kentucky | — | — |
| Not listed | Paducah | Kentucky | — | — |
| Not listed | Alexandria | Louisiana | — | — |
| Not listed | Covington | Louisiana | — | — |
| Not listed | Marrero | Louisiana | — | — |
| Not listed | Rockport | Maine | — | — |
| Not listed | Baltimore | Maryland | — | — |
| Not listed | Bethesda | Maryland | — | — |
| Not listed | Columbia | Maryland | — | — |
| Not listed | Boston | Massachusetts | — | — |
| Not listed | Worcester | Massachusetts | — | — |
| Not listed | Lansing | Michigan | — | — |
| Not listed | Jackson | Minnesota | — | — |
| Not listed | Lansing | Minnesota | — | — |
| Not listed | Bolivar | Missouri | — | — |
| Not listed | Cape Girardeau | Missouri | — | — |
| Not listed | Jefferson City | Missouri | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Billings | Montana | — | — |
| Not listed | Kalispell | Montana | — | — |
| Not listed | Grand Island | Nebraska | — | — |
| Not listed | Omaha | Nebraska | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Lebanon | New Hampshire | — | — |
| Not listed | Brick | New Jersey | — | — |
| Not listed | East Orange | New Jersey | — | — |
| Not listed | Florham Park | New Jersey | — | — |
| Not listed | Morristown | New Jersey | — | — |
| Not listed | Paramus | New Jersey | — | — |
| Not listed | Albany | New York | — | — |
| Not listed | Brooklyn | New York | — | — |
| Not listed | East Setauket | New York | — | — |
| Not listed | Elmira | New York | — | — |
| Not listed | New York | New York | — | — |
| Not listed | Rochester | New York | — | — |
| Not listed | Staten Island | New York | — | — |
| Not listed | Boone | North Carolina | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | Durham | North Carolina | — | — |
| Not listed | Greenville | North Carolina | — | — |
| Not listed | Hendersonville | North Carolina | — | — |
| Not listed | Canton | Ohio | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Cleveland | Ohio | — | — |
| Not listed | Toledo | Ohio | — | — |
| Not listed | Tualatin | Oregon | — | — |
| Not listed | Bethlehem | Pennsylvania | — | — |
| Not listed | Danville | Pennsylvania | — | — |
| Not listed | Dunmore | Pennsylvania | — | — |
| Not listed | Gettysburg | Pennsylvania | — | — |
| Not listed | Pittsburgh | Pennsylvania | — | — |
| Not listed | Willow Grove | Pennsylvania | — | — |
| Not listed | Lancaster | South Carolina | — | — |
| Not listed | Spartanburg | South Carolina | — | — |
| Not listed | Watertown | South Dakota | — | — |
| Not listed | Jackson | Tennessee | — | — |
| Not listed | Amarillo | Texas | — | — |
| Not listed | Arlington | Texas | — | — |
| Not listed | Beaumont | Texas | — | — |
| Not listed | Bryan | Texas | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | McAllen | Texas | — | — |
| Not listed | McKinney | Texas | — | — |
| Not listed | Mesquite | Texas | — | — |
| Not listed | Midland | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Wichita Falls | Texas | — | — |
| Not listed | Bristol | Virginia | — | — |
| Not listed | Seattle | Washington | — | — |
| Not listed | Yakima | Washington | — | — |
| Not listed | Martinsburg | West Virginia | — | — |
| Not listed | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02953704, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 12, 2022 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02953704 live on ClinicalTrials.gov.